Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling - Giulia Valdiserra; Clelia Di Salvo; Matteo Fornai; Luca Antonioli (Frontiers in Immunology)